The global coronavirus pandemic overwhelmed many health care systems, enforcing lockdown and encouraged work from home to control the spread of the virus and prevent overrunning of hospitalized patients. This prompted a sharp widespread use of telehe
alth to provide low-risk care for patients. Nevertheless, a continuous mutation into new variants and widespread unavailability of test kits, especially in developing countries, possess the challenge to control future potential waves of infection. In this paper, we propose a novel Smartphone application-based platform for early diagnosis of possible Covid-19 infected patients. The application provides three modes of diagnosis from possible symptoms, cough sound, and specific blood biomarkers. When a user chooses a particular setting and provides the necessary information, it sends the data to a trained machine learning (ML) model deployed in a remote server using the internet. The ML algorithm then predicts the possibility of contracting Covid-19 and sends the feedback to the user. The entire procedure takes place in real-time. Our machine learning models can identify Covid-19 patients with an accuracy of 100%, 95.65%, and 77.59% from blood parameters, cough sound, and symptoms respectively. Moreover, the ML sensitivity for blood and sound is 100%, which indicates correct identification of Covid positive patients. This is significant in limiting the spread of the virus. The multimodality offers multiplex diagnostic methods to better classify possible infectees and together with the instantaneous nature of our technique, demonstrates the power of telehealthcare as an easy and widespread low-cost scalable diagnostic solution for future pandemics.
The Reverse Transcription Polymerase Chain Reaction (RTPCR) test is the silver bullet diagnostic test to discern COVID infection. Rapid antigen detection is a screening test to identify COVID positive patients in little as 15 minutes, but has a lower
sensitivity than the PCR tests. Besides having multiple standardized test kits, many people are getting infected & either recovering or dying even before the test due to the shortage and cost of kits, lack of indispensable specialists and labs, time-consuming result compared to bulk population especially in developing and underdeveloped countries. Intrigued by the parametric deviations in immunological & hematological profile of a COVID patient, this research work leveraged the concept of COVID-19 detection by proposing a risk-free and highly accurate Stacked Ensemble Machine Learning model to identify a COVID patient from communally available-widespread-cheap routine blood tests which gives a promising accuracy, precision, recall & F1-score of 100%. Analysis from R-curve also shows the preciseness of the risk-free model to be implemented. The proposed method has the potential for large scale ubiquitous low-cost screening application. This can add an extra layer of protection in keeping the number of infected cases to a minimum and control the pandemic by identifying asymptomatic or pre-symptomatic people early.
